{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:58Z","timestamp":1788912058333,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32 GM008666"],"award-info":[{"award-number":["T32 GM008666"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006792","name":"Hartwell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY029166"],"award-info":[{"award-number":["EY029166"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HG004659"],"award-info":[{"award-number":["HG004659"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS103172"],"award-info":[{"award-number":["NS103172"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Methods"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ymeth.2022.06.008","type":"journal-article","created":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T11:28:29Z","timestamp":1656156509000},"page":"140-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Engineered U1 snRNAs to modulate alternatively spliced exons"],"prefix":"10.1016","volume":"205","author":[{"given":"Samuel T.","family":"Hatch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron A.","family":"Smargon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene W.","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ymeth.2022.06.008_b0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrg.2015.3","article-title":"RNA mis-splicing in disease","volume":"17","author":"Scotti","year":"2016","journal-title":"Nat. Rev. Genet."},{"issue":"9","key":"10.1016\/j.ymeth.2022.06.008_b0010","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/j.febslet.2005.02.047","article-title":"Are splicing mutations the most frequent cause of hereditary disease?","volume":"579","author":"Lopez-Bigas","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymeth.2022.06.008_b0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-3-319-89689-2_2","article-title":"Mechanism of splicing regulation of spinal muscular atrophy genes","volume":"20","author":"Singh","year":"2018","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.ymeth.2022.06.008_b0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-3-030-27378-1_15","article-title":"In Vivo Assessment of Potential Therapeutic Approaches for USH2A-Associated Diseases","volume":"1185","author":"Pendse","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"R2","key":"10.1016\/j.ymeth.2022.06.008_b0025","doi-asserted-by":"crossref","first-page":"R163","DOI":"10.1093\/hmg\/ddy171","article-title":"Exon-skipping advances for Duchenne muscular dystrophy","volume":"27","author":"Echevarria","year":"2018","journal-title":"Hum. Mol. Genet"},{"issue":"14","key":"10.1016\/j.ymeth.2022.06.008_b0030","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1093\/nar\/gkw533","article-title":"Splice-switching antisense oligonucleotides as therapeutic drugs","volume":"44","author":"Havens","year":"2016","journal-title":"Nucl. Acids Res."},{"issue":"1","key":"10.1016\/j.ymeth.2022.06.008_b0035","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-018-1482-5","article-title":"CRISPR-SKIP: programmable gene splicing with single base editors","volume":"19","author":"Gapinske","year":"2018","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.ymeth.2022.06.008_b0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16806-4","article-title":"CRISPR artificial splicing factors","volume":"11","author":"Du","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymeth.2022.06.008_b0045","doi-asserted-by":"crossref","first-page":"11168","DOI":"10.1038\/ncomms11168","article-title":"Therapeutic activity of modified U1 core spliceosomal particles","volume":"7","author":"Rogalska","year":"2016","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.ymeth.2022.06.008_b0050","doi-asserted-by":"crossref","first-page":"e3321","DOI":"10.1002\/jgm.3321","article-title":"U7 snRNA: a tool for gene therapy","volume":"23","author":"Gadgil","year":"2021","journal-title":"J. Gene Med."},{"issue":"11","key":"10.1016\/j.ymeth.2022.06.008_b0055","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1093\/hmg\/dds045","article-title":"An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects","volume":"21","author":"Fernandez Alanis","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ymeth.2022.06.008_b0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/wrna.1257","article-title":"Insights into the U1 small nuclear ribonucleoprotein complex superfamily","volume":"6","author":"Guiro","year":"2015","journal-title":"Wiley Interdiscip. Rev. RNA"},{"issue":"5","key":"10.1016\/j.ymeth.2022.06.008_b0065","first-page":"2666","article-title":"U1 small nuclear RNAs with altered specificity can be stably expressed in mammalian cells and promote permanent changes in pre-mRNA splicing","volume":"13","author":"Cohen","year":"1993","journal-title":"Mol. Cell. Biol."},{"issue":"22","key":"10.1016\/j.ymeth.2022.06.008_b0070","doi-asserted-by":"crossref","first-page":"10470","DOI":"10.1073\/pnas.91.22.10470","article-title":"Suppression of mammalian 5' splice-site defects by U1 small nuclear RNAs from a distance","volume":"91","author":"Cohen","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.ymeth.2022.06.008_b0075","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1128\/MCB.17.12.7099","article-title":"U1 small nuclear RNA-promoted exon selection requires a minimal distance between the position of U1 binding and the 3' splice site across the exon","volume":"17","author":"Hwang","year":"1997","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.ymeth.2022.06.008_b0080","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/jth.12471","article-title":"An engineered U1 small nuclear RNA rescues splicing defective coagulation F7 gene expression in mice","volume":"12","author":"Balestra","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.ymeth.2022.06.008_b0085","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ajhg.2014.12.009","article-title":"Improvement of SMN2 pre-mRNA processing mediated by exon-specific U1 small nuclear RNA","volume":"96","author":"Dal Mas","year":"2015","journal-title":"Am. J. Hum. Genet."},{"issue":"5154","key":"10.1016\/j.ymeth.2022.06.008_b0090","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1126\/science.7510905","article-title":"Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule","volume":"263","author":"Cheng","year":"1994","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ymeth.2022.06.008_b0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0050073","article-title":"Enhancement of SMN2 exon 7 inclusion by antisense oligonucleotides targeting the exon","volume":"5","author":"Hua","year":"2007","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ymeth.2022.06.008_b0100","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.18466.1","article-title":"Antisense-mediated splice intervention to treat human disease: the odyssey continues","volume":"8","author":"Pitout","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.ymeth.2022.06.008_b0105","doi-asserted-by":"crossref","unstructured":"P. Raguraman, et al., Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation. Cancers (Basel), 2021. 13(21).","DOI":"10.3390\/cancers13215555"},{"issue":"4","key":"10.1016\/j.ymeth.2022.06.008_b0110","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/mt.2013.276","article-title":"Dual masking of specific negative splicing regulatory elements resulted in maximal exon 7 inclusion of SMN2 gene","volume":"22","author":"Pao","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymeth.2022.06.008_b0115","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2105-13-134","article-title":"Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction","volume":"13","author":"Ye","year":"2012","journal-title":"BMC Bioinf."},{"issue":"1","key":"10.1016\/j.ymeth.2022.06.008_b0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ymeth.2022.06.008_b0125","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajhg.2009.08.002","article-title":"A positive modifier of spinal muscular atrophy in the SMN2 gene","volume":"85","author":"Prior","year":"2009","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ymeth.2022.06.008_b0130","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/21645698.2015.1137690","article-title":"A quick guide to CRISPR sgRNA design tools","volume":"6","author":"Brazelton","year":"2015","journal-title":"GM Crops Food"},{"issue":"12","key":"10.1016\/j.ymeth.2022.06.008_b0135","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/nbt.3026","article-title":"Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation","volume":"32","author":"Doench","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"11","key":"10.1016\/j.ymeth.2022.06.008_b0140","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1038\/mt.2012.178","article-title":"Exon 45 skipping through U1-snRNA antisense molecules recovers the Dys-nNOS pathway and muscle differentiation in human DMD myoblasts","volume":"20","author":"Cazzella","year":"2012","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.ymeth.2022.06.008_b0145","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/wrna.1158","article-title":"Targeting RNA splicing for disease therapy","volume":"4","author":"Havens","year":"2013","journal-title":"Wiley Interdiscip. Rev. RNA"},{"issue":"1","key":"10.1016\/j.ymeth.2022.06.008_b0150","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ymthe.2004.04.008","article-title":"A new vector, based on the PolII promoter of the U1 snRNA gene, for the expression of siRNAs in mammalian cells","volume":"10","author":"Denti","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymeth.2022.06.008_b0155","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13023-014-0180-y","article-title":"Therapeutic strategies based on modified U1 snRNAs and chaperones for Sanfilippo C splicing mutations","volume":"9","author":"Matos","year":"2014","journal-title":"Orphanet. J. Rare Dis."},{"issue":"4","key":"10.1016\/j.ymeth.2022.06.008_b0160","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ymeth.2005.07.015","article-title":"Use of minigene systems to dissect alternative splicing elements","volume":"37","author":"Cooper","year":"2005","journal-title":"Methods"},{"issue":"7","key":"10.1016\/j.ymeth.2022.06.008_b0165","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"issue":"10","key":"10.1016\/j.ymeth.2022.06.008_b0170","article-title":"An exon-specific U1snRNA induces a robust factor IX activity in mice expressing multiple human FIX splicing mutants","volume":"5","author":"Balestra","year":"2016","journal-title":"Mol. Ther. Nucl. Acids"},{"issue":"10","key":"10.1016\/j.ymeth.2022.06.008_b0175","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkr150","article-title":"U1 adaptors result in reduction of multiple pre-mRNA species principally by sequestering U1snRNP","volume":"39","author":"Vickers","year":"2011","journal-title":"Nucl. Acids Res."}],"container-title":["Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202322001487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202322001487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:44:48Z","timestamp":1760924688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046202322001487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":35,"alternative-id":["S1046202322001487"],"URL":"https:\/\/doi.org\/10.1016\/j.ymeth.2022.06.008","relation":{},"ISSN":["1046-2023"],"issn-type":[{"value":"1046-2023","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered U1 snRNAs to modulate alternatively spliced exons","name":"articletitle","label":"Article Title"},{"value":"Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymeth.2022.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 University of California San Diego. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}